The EMA has released guidance on the first steps it will take to prepare drug sponsors to comply with new data standards for the unique identification of drugs set to take effect in 2018.
Source: International Pharmaceutical Regulatory Monitor
The EMA has released guidance on the first steps it will take to prepare drug sponsors to comply with new data standards for the unique identification of drugs set to take effect in 2018.
Source: International Pharmaceutical Regulatory Monitor